Most Read Articles
Elvira Manzano, 2 days ago
Bisphosphonates have proven antifracture efficacy and remain to be the cornerstone of osteoporosis treatment. However, a drug holiday is of particular importance with bisphosphonates due to some signals with long-term use of the drug, including rare incidence of atypical femoral fracture (AFF) and osteonecrosis of the jaw (ONJ), says a leading endocrinologist at AFOS 2017.
07 Oct 2017
Women who follow a low-fat dietary pattern appear to have reduced breast cancer mortality, according to data from the Earlier Women’s Health Initiative Dietary Modification trial.
Pearl Toh, 6 days ago
Women with higher plasma tryptophan concentrations were less likely to have poor sleep quality during pregnancy, especially among those with anxiety symptoms, according to the GUSTO* study.
4 days ago
Second eye cataract surgery provides greater improvement in visual function and quality of life compared with first eye cataract surgery alone, a recent study claims.

Antidepressants show potential for managing depression in schizophrenia

01 Oct 2017

Antidepressants may be effective for treating depression in patients with schizophrenia, according to a meta-analysis that underscores qualifying conclusions based on the small number of low- or moderate-quality studies.

Researchers performed a meta-analysis of 26 trials that included adult patients with schizophrenia or related psychosis who had a depressive episode. Based on the Cochrane risk bias tool, the quality of the studies was moderate to low.

Pooled data indicated that antidepressants (eg, selective serotonin reuptake inhibitors [SSRIs], tricyclic antidepressants) had a favourable effect on the risk of depression compared with placebo, with a small risk difference –0.19 (95 percent CI, –0.27 to –0.11) and corresponding number needed to treat of 5 (4 to 9).

The effect size was larger in studies using tools specifically designed to assess depression in schizophrenia. On sensitivity analysis, however, standardized mean difference of all antidepressants, as well as any individual antidepressant class, showed no statistically significant improvement in depression score at endpoint.

In light of the methodological limitations of current published findings, researchers recommend that future large-scale trials should prioritize the appropriate measurement of depressive symptoms in schizophrenia, include reporting of adverse outcomes, and use an adequate method of randomization, allocation, concealment and specific depression inclusion criteria.   

Depression contributes to the extensive burden of schizophrenia, and its management is crucial to recovery. Improvement in depression status may result in better long-term functional outcomes, including medication adherence, service utilization, substance misuse, suicide attempts and quality of life. [Schizophr Res 2016;172:23–28]

Digital Edition
Asia's trusted medical magazine for healthcare professionals. Get your MIMS Doctor - Malaysia digital copy today!
DOWNLOAD
Editor's Recommendations
Most Read Articles
Elvira Manzano, 2 days ago
Bisphosphonates have proven antifracture efficacy and remain to be the cornerstone of osteoporosis treatment. However, a drug holiday is of particular importance with bisphosphonates due to some signals with long-term use of the drug, including rare incidence of atypical femoral fracture (AFF) and osteonecrosis of the jaw (ONJ), says a leading endocrinologist at AFOS 2017.
07 Oct 2017
Women who follow a low-fat dietary pattern appear to have reduced breast cancer mortality, according to data from the Earlier Women’s Health Initiative Dietary Modification trial.
Pearl Toh, 6 days ago
Women with higher plasma tryptophan concentrations were less likely to have poor sleep quality during pregnancy, especially among those with anxiety symptoms, according to the GUSTO* study.
4 days ago
Second eye cataract surgery provides greater improvement in visual function and quality of life compared with first eye cataract surgery alone, a recent study claims.